As a result, tremendous efforts have been made to counteract survivin activities in cancer cells through the utilization of antisense oligonucleotides [18-23], ribozymes [24-26], small interfering RNA [27, 28], and dominant negative survivin [29-31]. The gene discussed is BIRC5; the disease is cancer.